Search clinical trials for: PN 400 (VIMOVO)

Total 12621 results

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers

Asthma; Allergic Rhinitis

China
POZEN

Completed

Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

Osteoarthritis

United States
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
JMackem Co., Ltd
Seoul National University Hospital

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Diabetic Neuropathies | Neuropathic Pain | Post Herpetic Neuralgia

Korea, Republic of
The University of Texas Health Science Center at...
Susan G. Komen Breast Cancer Foundation

Completed

Komen Breast Cancer Survivor Health Screening Promotion Project: Staying Healthy

Breast Cancer
The University of Texas Health Science Center at...
National Cancer Institute (NCI)

Completed

Redes III Patient Navigator Qol Study

Breast Cancer | Colorectal Cancer | Prostate Cancer

United States
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

MELAS Syndrome | Mitochondrial Respiratory Chain Deficiencies

Korea, Republic of
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Neoplasms | Multiple Myeloma | Lymphoma, Malignant | Thrombocytopenia

United States, Argentina, Mexico
Janssen Research & Development, LLC

Completed

A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants

Healthy

China
Janssen Research & Development, LLC

Completed

A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis (SUMMIT)

Plaque Psoriasis

United States, Canada, Germany, France, Spain, Poland
Columbia University
National Institute on Drug Abuse (NIDA)

Completed

Seek, Test, and Retain. Linkages for Black HIV+, Substance-Using MSM (STAR)

Sexual Behavior | Substance Abuse

United States
POZEN

Completed

A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

Gastric Ulcer

United States
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Sarcoma

United States
Johns Hopkins University
National Institute of Nursing Research (NINR)

Active, not recruiting

Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

Pelvic Inflammatory Disease

United States
PluroGen Therapeutics, Inc
Arkios BioDevelopment International

Completed

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

Diabetic Foot Ulcer | Infection

United States
Ilkos Therapeutic Inc.

Completed

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Venous Leg Ulcer

Spain, Hungary, Canada, United States, Brazil, Argentina, Austria, Czechia, Italy, Poland, Slovakia
NYU Langone Health
Centers for Disease Control and Prevention

Recruiting

NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation (NYC CONNECT)

Cancer Screening

United States
Paean Biotechnology Inc.

Completed

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

Dermatomyositis | Polymyositis

Korea, Republic of
Northwestern University
Northeastern Illinois University

Recruiting

Patient Navigation 2.0

Cancer

United States
POZEN

Completed

An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers

Healthy

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Australian and New Zealand Intensive Care Research...
Baxter Healthcare Corporation

Completed

Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Trial

Critical Illness | Multiple Organ Failure

Australia, New Zealand
Protagonist Therapeutics, Inc.

Completed

PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Severe

United States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics of PN-232 in Healthy Volunteers

Healthy Subjects

Australia
Pfizer

Withdrawn

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Ulcerative Colitis

United States
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Influenza A

China
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
KU Leuven
Stollery Children's Hospital; Sophia Kindergeneeskunde

Active, not recruiting

Early Versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit (PEPaNIC)

Critical Illness | Children

Canada, Belgium, Netherlands
CymaBay Therapeutics, Inc.

Completed

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Healthy Volunteers

Australia
Icahn School of Medicine at Mount Sinai

Completed

Latino Peers as Patient Navigators for Colon Cancer Screening

Colon Cancer

United States
NYU Langone Health

Completed

Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City (MARHABA)

Cervical Cancer | Breast Cancer

United States
Ospedali Riuniti Ancona
Azienda Ospedaliera di Padova; Hospital Universitario La Paz

Recruiting

Personalized vs Standardized PN for Preterm Infants >1250g

Growth | Parenteral Nutrition | Infant,Premature

Spain, Italy
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Peer Patient Navigation for Colon Cancer Screening

Screening Colonoscopy

United States
Ridgeback Biotherapeutics, LP
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

SARS-CoV-2 Infection, COVID-19

United States
DEXLEVO

Completed

To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet (dermal filler)

Crow's Feet Lines

Korea, Republic of
Johns Hopkins Bloomberg School of Public Health
National Institute on Drug Abuse (NIDA); University of Wisconsin, Madison

Completed

Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care (mP2P)

HIV | Drug Use

United States
University of Utah
National Institutes of Health (NIH); National Center for Advancing Translational... and other collaborators

Completed

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers

Covid19

United States
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics of PN-235 in Healthy Volunteers

Healthy Volunteers

Australia
M.D. Anderson Cancer Center
Centers for Medicare and Medicaid Services

Completed

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

Cervical Cancer | Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

United States
Merck Sharp & Dohme LLC

Completed

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Hepatitis C Virus Infection
Innovation Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Chronic Stable Plaque Psoriasis

United States
POZEN

Completed

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

Osteoarthritis | Rheumatoid Arthritis | Ankylosing Spondylitis

United States
Pfizer

Completed

Genotropin Treatment In Very Young Children Born Small For Gestational Age (EGN)

Infant, Small for Gestational Age

Czech Republic, Spain, Sweden, Netherlands, Belgium, France, Germany, Italy, Switzerland
Galapagos NV

Completed

A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis

Cystic Fibrosis

Spain, United Kingdom, United States, Netherlands, Belgium, Serbia
GlaxoSmithKline

Terminated

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

Systemic Lupus Erythematosus

Estonia, Germany, South Africa, Peru, Sweden, France, Korea, Republic of, Hong Kong, Spain, Romania, Czechia, Argentina, Chile, Hungary, Greece, Poland
Lexicon Pharmaceuticals

Completed

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
Pennington Biomedical Research Center

Completed

Geranium Oil and Its Components for the Relief of Numbness-OB 100

Numbness | Nerve Conduction

United States
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Hodgkin Disease | Thrombocytopenia | Non-Hodgkin Lymphoma

United States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland

Search clinical trials for: PN 400 (VIMOVO)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations